A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284

Clinical trial NCT06884098 · RECRUITING

Trial details

NCT number: NCT06884098
Sponsor: Addpharma Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Hypercholesterolaemia

Start date: 2025-03-10
Primary completion: 2025-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.